Human medicines
Ranitidin 1A Pharma, Ranic Hexal
Recall
|
Medicines
|
17/09/2019
The marketing authorisation holder informed its customers on September 16, 2019 that a review of ranitidine medicines after tests showed an impurity called N-nitrosodimethylamine (NDMA).
Ranitidin 1A Pharma, Ranic Hexal
Read more
Zomig 5 mg Nasenspray
Recall
|
Medicines
|
13/09/2019
The marketing authorisation holder informed its customers on September 13, 2019 that below mentioned batch is recalled because of a incorrect package leaflet.
Zomig 5 mg Nasenspray
Read more
Lomaherpan Fieberblasen - Creme
Recall
|
Medicines
|
23/08/2019
The marketing authorisation holder informed its customers on August 23, 2019 that below mentioned batch is recalled because the content of the active substance is below specification limits.
Lomaherpan Fieberblasen - Creme
Read more
Ropinaest
Recall
|
Medicines
|
01/08/2019
The marketing authorisation holder informed its customers on August 1, 2019 that the outer packaging may leak.
Ropinaest
Read more
Elotrace
Recall
|
Medicines
|
03/07/2019
The marketing authorisation holder informed its customers on July 3, 2019 that below mentioned batch of „Elotrace - Infusionszusatz“ show black visible particles.
Elotrace
Read more
Hydal retard
Recall
|
Medicines
|
14/05/2019
The marketing authorisation holder informed its customers on May 13, 2019 that overweight capsules may be packed and distributed to the market.
Hydal retard
Read more
NaCl- und Glucoseinfusionslösungen
Recall
|
Medicines
|
26/04/2019
"MEDIKUS medizintechnische und pharmazeutische Vertriebs GmbH" informed its customers on April 26, 2019 that metallic particles were detected in the infusion bags.
NaCl- und Glucoseinfusionslösungen
Read more
Parkemed
Recall
|
Medicines
|
05/04/2019
The marketing authorisation holder informed its customers on April 4, 2019 that there is a risk that "Parkemed - Suspension zur oralen Anwendung" will likely contain levels of Lead (Pb) and Lithium (Li) which exceed the Permitted Daily Exposure (PDE) levels.
Parkemed
Read more
Tetraspan, Venofundin
Recall
|
Medicines
|
11/03/2019
The marketing authorisation holder informed its customers on March 6, 2019 that the marketing of „Tetraspan 60 mg/ml Infusionslösung“ and „Venofundin 60 mg/ml Infusionslösung“ is ceased permanently for economic reasons.
Tetraspan, Venofundin
Read more
Vantobra
Recall
|
Medicines
|
21/02/2019
The marketing authorisation holder informed its customers on February 19, 2019 that the marketing authorisation of „Vantobra 170 mg Lösung für einen Vernebler“ will be withdrawn.
Vantobra
Read more